Multiple Sclerosis (MS) Drug Market

RECENT NEWS
newratings.com  Jun 30  Comment 
SOUTH SAN FRANCISCO (dpa-AFX) - Genentech, a member of the Roche Group (RHHBY.PK), announced positive results from two pivotal studies evaluating the investigational medicine ocrelizumab compared with interferon beta-1a (Rebif),...
New York Times  Jun 18  Comment 
A federal appeals court on Thursday again invalidated a patent protecting Teva Pharmaceutical’s big-selling drug, Copaxone, which can cost $60,000 a year.
Benzinga  Jun 9  Comment 
RedHill Biopharma Ltd. (Nasdaq: RDHL) (TASE:RDHL) ("RedHill" or the "Company"), an Israeli biopharmaceutical company focused on late clinical-stage, proprietary, orally-administered, small molecule drugs for inflammatory and gastrointestinal...
Benzinga  May 29  Comment 
Alkermes plc (NASDAQ: ALKS) today announced that data from its phase 1, randomized, double-blind clinical study of ALKS 8700, a novel monomethyl fumarate (MMF) molecule in development for the treatment of multiple sclerosis (MS), is scheduled to...
FierceBiotech  May 28  Comment 
Mapi Pharma has closed a $10 million (€9 million) Series A round to finance mid-phase trials of its once-a-month version of Teva's blockbuster multiple sclerosis drug, Copaxone. The round follows two aborted attempts to raise cash in a Nasdaq IPO.
NPR  May 25  Comment 
The cost of medication to treat multiple sclerosis has risen much faster than inflation, even for older drugs. Patients and insurers say manufacturers' subsidy programs have helped, but not enough.
FierceBiotech  May 21  Comment 
Ablynx has entered into a collaboration with Sanofi's Genzyme to investigate the use of its single-domain antibodies against a target involved with multiple sclerosis. The deal gives Genzyme the exclusive right to test the antibodies in models...
Wall Street Journal  May 1  Comment 
Drugs for diseases such as cancer and multiple sclerosis account for more than a quarter of spending on prescriptions for America’s elderly and disabled, data show.
MedPage Today  Apr 27  Comment 
(MedPage Today) -- Water-soluble vitamin bests placebo in progressive multiple sclerosis.




 
TOP CONTRIBUTORS

Very nice site!

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki